Latest news

Insights

Top 10 Digital Capabilities Separating Industry Leaders

Executive Summary Digital maturity is becoming a competitive differentiator across the pharmaceutical and biotechnology industries. While many organizations invest in...
Commercial

Astellas wagers $1.3 billion on Audax’s preclinical effort to end decades of IL-12 problems

Financial Terms and Partnership Scope Astellas has agreed to up to $285 million in upfront and option payments to get...
Technology

Vera Health Raises $28.5 Million to Expand Clinical AI Search Platform

Vera Health, a clinical artificial intelligence search engine, has secured $28.5 million in Series A funding to expand its...
Clinical

Novartis Reports Late-Stage Trial Setbacks for Del-Desiran and Pelacarsen

Novartis reported late-stage clinical trial failures for two experimental medicines in September, including del-desiran, which was being developed for...
Commercial

Menarini’s Stemline Signs Huge Deal With Georgiamine For Preclincal Cancer Drug

Georgiamune, a Maryland-based biotechnology company focused on immunology, has...
Clinical

Roivant Sets Sights on Humira as Lisraya Performs Well in Eye Disease Study

Following Lisraya’s first regulatory approval, Roivant and its subsidiary...
Clinical

BMS Reports Positive Phase 3 Results for Iza-Bren in Lung and Breast Cancer

Bristol Myers Squibb (BMS) has reported positive results from two phase 3 trials of izalontamab brengitecan (iza-bren), a bispecific...
Clinical

BioNTech Reports Modest Benefit and Safety Concerns in Phase 3 Breast Cancer Trial

BioNTech and DualityBio have reported topline results from DYNASTY-Breast02, a global phase 3 clinical trial evaluating trastuzumab pamirtecan (t-pam)...
Regulatory

GSK’s Hepatitis B Drug Gets FDA Green Light

GSK has secured U.S. approval for bepirovirsen, an antisense oligonucleotide licensed from Ionis Pharmaceuticals, marking a milestone in the...
Insights

Real-Time Commercial Intelligence in Life Sciences

Executive Summary Pharmaceutical commercial teams are operating in markets where...
Insights

Top 10 AI Skills Every Life Sciences Leader Needs

Executive Summary Artificial intelligence is reshaping drug discovery, clinical development,...
Insights

Digital Therapeutics 2.0: The Next Phase of Software-Based Treatment

Executive Summary Digital therapeutics (DTx) are evolving beyond standalone software interventions toward more personalized, connected, and clinically integrated treatment experiences....
Clinical

Disc Medicine’s Bitopertin Meets Phase 3 Goals in Rare Sunlight-Sensitivity Disorder

Disc Medicine has reported that its experimental drug bitopertin met all primary and secondary endpoints in a phase 3...
Commercial

AstraZeneca Pens $1.5B Deal With Insitro Targeting Cardiometabolic Diseases

AstraZeneca will pay insitro $40 million upfront to use artificial intelligence to identify new therapeutic targets for liver and...
Commercial

Life Sciences Voice In Collaboration With Future Pharma EU 2026

Future Pharma Europe returns on 20–21 October 2026 in...
Editorial Team -
Commercial

Novartis to combine its pharma and oncology operations to save $1 Billion

Novartis has opted for a corporate restructure of operations...
Commercial

Novartis Secures $3.2 Billion Acquisition of Chinook to Enhance Kidney Disease Strategy

Novartis, the Swiss pharmaceutical giant, is set to bolster...

Popular

Most popular life news you must read today

View all articles

Commercial

Information Technology

Vera Health Raises $28.5 Million to Expand Clinical AI Search Platform

Vera Health, a clinical artificial intelligence search engine, has secured $28.5 million in Series...
Editorial Team -

Suki Launches AI Dictation Tool Integrated With Epic and Meditech EHRs

Suki announced Tuesday the release of Suki Dictation, an artificial intelligence-powered dictation solution designed...
Editorial Team -

Claryx Appears From Stealth to Deal with the $45B Hospital-Acquired Infections Issue

Healthcare-related infections remain a persistent challenge for hospitals, affecting roughly one in every 40...
Editorial Team -

J&J’s OTTAV Robotic Surgical System has received FDA market authorization in the U.S.

The U.S. Food and Drug Administration (FDA) granted Johnson & Johnson De Novo clearance...
Editorial Team -

Regulatory

Regulatory

GSK’s Hepatitis B Drug Gets FDA Green Light

GSK has secured U.S. approval for bepirovirsen, an antisense...
Editorial Team -
Commercial

Astellas wagers $1.3 billion on Audax’s preclinical effort to end decades of IL-12 problems

Financial Terms and Partnership Scope Astellas has agreed to up...
Technology

Vera Health Raises $28.5 Million to Expand Clinical AI Search Platform

Vera Health, a clinical artificial intelligence search engine, has...
Clinical

Novartis Reports Late-Stage Trial Setbacks for Del-Desiran and Pelacarsen

Novartis reported late-stage clinical trial failures for two experimental...
Insights

Top 10 Metrics Clinical Operations Leaders Should Track

Executive Summary Clinical operations leaders must balance trial speed, cost,...

Research & Development

Market Access

Manufacturing

Edgewise Reports Phase 2 CIRRUS-HCM Results for EDG-7500 Ahead of Planned Phase 3 Development

Edgewise Therapeutics has reported top-line results from Part D...
Manufacturing

Genentech signs a $490 million breast cancer partnership and lays off 103 employees with gRED Rethink

The Roche subsidiary has just announced that the restructuring...

Manufacturing & RegulatoryPOPULAR
Find Your Perfect Music Festival

Insights

Top 10 Digital Capabilities Separating Industry Leaders

Executive Summary Digital maturity is becoming a competitive differentiator across...
Editorial Team -
Technology

Vera Health Raises $28.5 Million to Expand Clinical AI Search Platform

Vera Health, a clinical artificial intelligence search engine, has...
Editorial Team -